{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:03:19Z","timestamp":1769972599811,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T00:00:00Z","timestamp":1193184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/sj.npp.1301572","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T09:20:24Z","timestamp":1193217624000},"page":"1856-1863","source":"Crossref","is-referenced-by-count":86,"title":["Naltrexone Attenuates the Subjective Effects of Amphetamine in Patients with Amphetamine Dependence"],"prefix":"10.1038","volume":"33","author":[{"given":"Nitya","family":"Jayaram-Lindstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Konstenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staffan","family":"Eksborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hammarberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Franck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,24]]},"reference":[{"key":"BF1301572_CR1","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","volume":"156","author":"RF Anton","year":"1999","unstructured":"Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999). Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156: 1758\u20131764.","journal-title":"Am J Psychiatry"},{"key":"BF1301572_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF01061504","volume":"2","author":"HG Boxenbaum","year":"1974","unstructured":"Boxenbaum HG, Riegelman S, Elashoff RM (1974). Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2: 123\u2013148.","journal-title":"J Pharmacokinet Biopharm"},{"key":"BF1301572_CR3","unstructured":"CAN (2001). Drogutvecklingen i Sverige, rapport 99. Rapport nr10 (1999). Folkh\u00e4lsoinstitutet: Centralf\u00f6rbundet f\u00f6r Alkol och Narkotikaupplysning, Stockholm [The development of drug use in Sweden, report 2001]."},{"key":"BF1301572_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","volume":"35","author":"J Chick","year":"2000","unstructured":"Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R et al (2000). A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35: 587\u2013593.","journal-title":"Alcohol Alcohol"},{"key":"BF1301572_CR5","first-page":"1970","volume":"74","author":"P Cushman Jr","year":"1974","unstructured":"Cushman P Jr, Kreek MJ (1974). Methadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin. NY State J Med 74: 1970\u20131973.","journal-title":"NY State J Med"},{"key":"BF1301572_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0169-2607(85)90085-9","volume":"20","author":"A Dunne","year":"1985","unstructured":"Dunne A (1985). JANA: A new iterative polyexponential curve stripping program. Comput Methods Programs Biomed 20: 269\u2013275.","journal-title":"Comput Methods Programs Biomed"},{"key":"BF1301572_CR7","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1046\/j.1460-9568.2003.02636.x","volume":"17","author":"P Fagergren","year":"2003","unstructured":"Fagergren P, Smith HR, Daunais JB, Nader MA, Porrino LJ, Hurd YL (2003). Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration. Eur J Neurosci 17: 2212\u20132218.","journal-title":"Eur J Neurosci"},{"key":"BF1301572_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.biopsych.2005.02.026","volume":"57","author":"DA Gorelick","year":"2005","unstructured":"Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M et al (2005). Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 57: 573\u2013582.","journal-title":"Biol Psychiatry"},{"key":"BF1301572_CR9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/0028-3908(82)90114-9","volume":"21","author":"R Hitzemann","year":"1982","unstructured":"Hitzemann R, Curell J, Hom D (1982). Effects of naloxone on d-amphetamine- and apomorphine-induced behavior. Neuropharmacology 21: 1005\u20131011.","journal-title":"Neuropharmacology"},{"key":"BF1301572_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0014-2999(89)90066-6","volume":"166","author":"YL Hurd","year":"1989","unstructured":"Hurd YL, Ungerstedt U (1989). In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol 166: 251\u2013260.","journal-title":"Eur J Pharmacol"},{"key":"BF1301572_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1300\/J069v24n03_11","volume":"24","author":"C Jaffe","year":"2005","unstructured":"Jaffe C, Bush KR, Straits-Troster K, Meredith C, Ronwall L, Rosenbaum G et al (2005). A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. J Addict Dis 24: 133\u2013152.","journal-title":"J Addict Dis"},{"key":"BF1301572_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","volume":"24","author":"N Jayaram-Lindstrom","year":"2004","unstructured":"Jayaram-Lindstrom N, Wennberg P, Hurd YL, Franck J (2004). Effects of naltrexone on the subjective response to amphetamine in healthy volunteers. J Clin Psychopharmacol 24: 665\u2013669.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1301572_CR13","first-page":"638","volume":"262","author":"DN Jones","year":"1992","unstructured":"Jones DN, Holtzman SG (1992). Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors. J Pharmacol Exp Ther 262: 638\u2013645.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301572_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0022-3956(87)90031-8","volume":"21","author":"PR Joyce","year":"1987","unstructured":"Joyce PR, Donald RA (1987). Naloxone augments the hypothalamic\u2013pituitary\u2013adrenal axis response to methylphenidate in normal subjects. J Psychiatr Res 21: 297\u2013300.","journal-title":"J Psychiatr Res"},{"key":"BF1301572_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00001756-200302100-00019","volume":"14","author":"EA Kiyatkin","year":"2003","unstructured":"Kiyatkin EA, Brown PL (2003). Naloxone depresses cocaine self-administration and delays its initiation on the following day. Neuroreport 14: 251\u2013255.","journal-title":"Neuroreport"},{"key":"BF1301572_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0006-3223(92)90223-M","volume":"32","author":"T Kosten","year":"1992","unstructured":"Kosten T, Silverman DG, Fleming J, Kosten TA, Gawin FH, Compton M et al (1992). Intravenous cocaine challenges during naltrexone maintenance: a preliminary study. Biol Psychiatry 32: 543\u2013548.","journal-title":"Biol Psychiatry"},{"key":"BF1301572_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0024-3205(97)00130-6","volume":"60","author":"AV Kuzmin","year":"1997","unstructured":"Kuzmin AV, Gerrits MA, van Ree JM (1997). Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice. Life Sci 60: 257\u2013264.","journal-title":"Life Sci"},{"key":"BF1301572_CR18","first-page":"1207","volume":"29","author":"MC Lee","year":"1988","unstructured":"Lee MC, Wagner HN, Tanada S, Frost JJ, Bice AN, Dannals RF (1988). Duration of occupancy of opiate receptors. J Nucl Med 29: 1207\u20131211.","journal-title":"J Nucl Med"},{"key":"BF1301572_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971). Physiologic, subjective, and behavioural effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12: 245\u2013258.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1301572_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/10826087309062056","volume":"8","author":"DG Mayfield","year":"1973","unstructured":"Mayfield DG (1973). The effect of intravenous methamphetamine on mood. Int J Addict 8: 565\u2013568.","journal-title":"Int J Addict"},{"key":"BF1301572_CR21","volume-title":"Manual for the Profile of Mood States","author":"DM McNair","year":"1971","unstructured":"McNair DM, Lorr M, Droppleman LF (1971). Manual for the Profile of Mood States. Educational and Industrial Testing Service: San Diego, CA."},{"key":"BF1301572_CR22","first-page":"15","volume":"45","author":"MC Meyer","year":"1984","unstructured":"Meyer MC, Straughn AB, Lo MW (1984). Bioequivalence, dose-proportionality and pharmacokinetics of naltrexone after oral administration. Clin Psychiatry 45: 15\u201319.","journal-title":"Clin Psychiatry"},{"key":"BF1301572_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00432677","volume":"74","author":"D Naber","year":"1981","unstructured":"Naber D, Pickar D, Davis GC, Cohen RM, Jimerson DC, Elchisak MA et al (1981). Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers. Psychopharmacology (Berl) 74: 125\u2013128.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301572_CR24","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1176\/appi.ajp.162.8.1423","volume":"162","author":"CP O'Brien","year":"2005","unstructured":"O'Brien CP (2005). Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 162: 1423\u20131431.","journal-title":"Am J Psychiatry"},{"key":"BF1301572_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","volume":"49","author":"SS O'Malley","year":"1992","unstructured":"O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992). Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49: 881\u2013887.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301572_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0740-5472(98)00039-7","volume":"16","author":"DW Oslin","year":"1999","unstructured":"Oslin DW, Pettinati HM, Volpicelli JR, Wolf AL, Kampman KM, O'Brien CP (1999). The effects of naltrexone on alcohol and cocaine use in dually addicted patients. J Subst Abuse Treat 16: 163\u2013167.","journal-title":"J Subst Abuse Treat"},{"key":"BF1301572_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0306-4603(00)00098-8","volume":"26","author":"JM Schmitz","year":"2001","unstructured":"Schmitz JM, Stotts AL, Rhoades HM, Grabowski J (2001). Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict Behav 26: 167\u2013180.","journal-title":"Addict Behav"},{"key":"BF1301572_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/10550490490480982","volume":"13","author":"JM Schmitz","year":"2004","unstructured":"Schmitz JM, Stotts AL, Sayre SL, DeLaune KA, Grabowski J (2004). Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy. Am J Addic 13: 333\u2013341.","journal-title":"Am J Addic"},{"key":"BF1301572_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0091-3057(03)00157-6","volume":"75","author":"M Sofuoglu","year":"2003","unstructured":"Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A (2003). Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav 75: 801\u2013808.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301572_CR30","doi-asserted-by":"crossref","unstructured":"Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P (2001). Treatment for amphetamine dependence and abuse. Cochrane Database Syst Rev CD003022.","DOI":"10.1002\/14651858.CD003022"},{"key":"BF1301572_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2307\/2683122","volume":"40","author":"Statistical Consultants Inc.","year":"1986","unstructured":"Statistical Consultants Inc. (1986). PCNONLIN and NONLIN 84. Software for the statistical analysis of nonlinear models. Am Stat 40: 52.","journal-title":"Am Stat"},{"key":"BF1301572_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0376-8716(93)90042-O","volume":"34","author":"ST Tiffany","year":"1993","unstructured":"Tiffany ST, Singleton E, Haertzen CA, Henningfield JE (1993). The development of a cocaine craving questionnaire. Drug Alcohol Depend 34: 19\u201328.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301572_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF02244190","volume":"104","author":"KA Trujillo","year":"1991","unstructured":"Trujillo KA, Belluzzi JD, Stein L (1991). Naloxone blockade of amphetamine place preference conditioning. Psychopharmacology (Berl) 104: 265\u2013274.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301572_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0091-3057(89)90444-9","volume":"33","author":"KA Trujillo","year":"1989","unstructured":"Trujillo KA, Belluzzi JD, Stein L (1989). Naloxone suppression of self-stimulation is independent of response difficulty. Pharmacol Biochem Behav 33: 147\u2013155.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301572_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2005.06.010","volume":"108","author":"F Vocci","year":"2005","unstructured":"Vocci F, Ling W (2005). Medications development: successes and challenges. Pharmacol Ther 108: 94\u2013108.","journal-title":"Pharmacol Ther"},{"key":"BF1301572_CR36","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992). Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876\u2013880.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301572_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0006-8993(94)01422-E","volume":"673","author":"JQ Wang","year":"1995","unstructured":"Wang JQ, McGinty JF (1995). Alterations in striatal zif\/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res 673: 262\u2013274.","journal-title":"Brain Res"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301572","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:56:36Z","timestamp":1684220196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,24]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BF1301572"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301572","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,24]]}}}